Literature DB >> 15452040

Pathogenesis of persistent hyperplastic primary vitreous in mice lacking the arf tumor suppressor gene.

Amy C Martin1, J Derek Thornton, Jiewiu Liu, XiaoFei Wang, Jian Zuo, Monica M Jablonski, Edward Chaum, Frederique Zindy, Stephen X Skapek.   

Abstract

PURPOSE: Persistent hyperplastic primary vitreous (PHPV) is an idiopathic developmental eye disease associated with failed involution of the hyaloid vasculature. The present work addressed the pathogenesis of PHPV in a mouse model that replicates many aspects of the human disease.
METHODS: Ophthalmoscopic and histologic analyses documented pathologic processes in eyes of mice lacking the Arf gene compared with Ink4a-deficient and wild-type control animals. Immunohistochemical staining, in situ hybridization, and RT-PCR demonstrated the expression of relevant gene products. Arf gene expression was determined by in situ hybridization using wholemounts of wild-type mouse eyes and by immunofluorescence staining for green fluorescent protein (GFP) in Arf(+/GFP) heterozygous knock-in mouse eyes.
RESULTS: Abnormalities in Arf(-/-) mice mimicked those found in patients with severe PHPV. The mice had microphthalmia; fibrovascular, retrolental tissue containing retinal pigment epithelial cells and remnants of the hyaloid vascular system; posterior lens capsule destruction with lens degeneration and opacity; and severe retinal dysplasia and detachment. Eyes of mice lacking the overlapping Ink4a gene were normal. Arf was selectively expressed in perivascular cells within the vitreous of the postnatal eye. Cells composing the retrolental mass in Arf(-/-) mice expressed the Arf promoter. The remnant hyaloid vessels expressed Flk-1. Its ligand, vascular endothelial growth factor (Vegf), was expressed in the retrolental tissue and the adjacent dysplastic neuroretina.
CONCLUSIONS: Arf(-/-) mice have features that accurately mimic severe PHPV. In the HVS, Arf expression in perivascular cells may block their accumulation or repress Vegf expression to promote HVS involution and prevent PHPV.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452040      PMCID: PMC1557705          DOI: 10.1167/iovs.04-0349

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  59 in total

1.  Norrie disease. Diagnosis of a simplex case by DNA analysis.

Authors:  E W Chynn; D S Walton; L B Hahn; T P Dryja
Journal:  Arch Ophthalmol       Date:  1996-09

2.  Study of the Norrie disease gene in 2 patients with bilateral persistent hyperplastic primary vitreous.

Authors:  S D Pendergast; M T Trese; X Liu; B S Shastry
Journal:  Arch Ophthalmol       Date:  1998-03

Review 3.  The pericyte--a review.

Authors:  D E Sims
Journal:  Tissue Cell       Date:  1986       Impact factor: 2.466

4.  Persistent hyperplastic primary vitreous in non-identical twins.

Authors:  M K Wang; C I Phillips
Journal:  Acta Ophthalmol (Copenh)       Date:  1973

5.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice.

Authors:  P Lindahl; B R Johansson; P Levéen; C Betsholtz
Journal:  Science       Date:  1997-07-11       Impact factor: 47.728

6.  ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.

Authors:  Y Zhang; Y Xiong; W G Yarbrough
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

7.  The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.

Authors:  J Pomerantz; N Schreiber-Agus; N J Liégeois; A Silverman; L Alland; L Chin; J Potes; K Chen; I Orlow; H W Lee; C Cordon-Cardo; R A DePinho
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

8.  Differential expression of VEGF isoforms in mouse during development and in the adult.

Authors:  Y S Ng; R Rohan; M E Sunday; D E Demello; P A D'Amore
Journal:  Dev Dyn       Date:  2001-02       Impact factor: 3.780

9.  Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.

Authors:  T Kamijo; J D Weber; G Zambetti; F Zindy; M F Roussel; C J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

10.  Mutations in the Norrie disease gene.

Authors:  D E Schuback; Z Y Chen; I W Craig; X O Breakefield; K B Sims
Journal:  Hum Mutat       Date:  1995       Impact factor: 4.878

View more
  27 in total

Review 1.  Vascular endothelial growth factor biology: clinical implications for ocular treatments.

Authors:  R B Bhisitkul
Journal:  Br J Ophthalmol       Date:  2006-12       Impact factor: 4.638

2.  Evisceration of mouse vitreous and retina for proteomic analyses.

Authors:  Jessica M Skeie; Stephen H Tsang; Vinit B Mahajan
Journal:  J Vis Exp       Date:  2011-04-03       Impact factor: 1.355

3.  miR-34a is essential for p19(Arf)-driven cell cycle arrest.

Authors:  Nida Iqbal; Jie Mei; Jing Liu; Stephen X Skapek
Journal:  Cell Cycle       Date:  2014-01-08       Impact factor: 4.534

4.  Phenotype screening for genetically determined age-onset disorders and increased longevity in ENU-mutagenized mice.

Authors:  Dabney K Johnson; Eugene M Rinchik; Naima Moustaid-Moussa; Darla R Miller; Robert W Williams; Edward J Michaud; Monica M Jablonski; Andrea Elberger; Kristen Hamre; Richard Smeyne; Elissa Chesler; Daniel Goldowitz
Journal:  Age (Dordr)       Date:  2005-05-02

5.  ARF suppresses hepatic vascular neoplasia in a carcinogen-exposed murine model.

Authors:  Stephanie E Busch; Kay E Gurley; Russell D Moser; Christopher J Kemp
Journal:  J Pathol       Date:  2012-05-08       Impact factor: 7.996

6.  Identification of De Novo Enhancers Activated by TGFβ to Drive Expression of CDKN2A and B in HeLa Cells.

Authors:  Yen-Ting Liu; Lin Xu; Lynda Bennett; Jared C Hooks; Jing Liu; Qinbo Zhou; Priscilla Liem; Yanbin Zheng; Stephen X Skapek
Journal:  Mol Cancer Res       Date:  2019-06-12       Impact factor: 5.852

7.  Formation of persistent hyperplastic primary vitreous in ephrin-A5-/- mice.

Authors:  Alexander I Son; Michal Sheleg; Margaret A Cooper; Yuhai Sun; Norman J Kleiman; Renping Zhou
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-19       Impact factor: 4.799

8.  Isolation and characterization of mammalian cells expressing the Arf promoter during eye development.

Authors:  Nida S Iqbal; Lin Xu; Caitlin C Devitt; Stephen X Skapek
Journal:  Biotechniques       Date:  2014-05-01       Impact factor: 1.993

9.  p19Arf represses platelet-derived growth factor receptor β by transcriptional and posttranscriptional mechanisms.

Authors:  Ryan C Widau; Yanbin Zheng; Caroline Y Sung; Anna Zelivianskaia; Lauren E Roach; Karen M Bachmeyer; Tatiana Abramova; Aurelie Desgardin; Andrew Rosner; John M Cunningham; Stephen X Skapek
Journal:  Mol Cell Biol       Date:  2012-08-20       Impact factor: 4.272

10.  A monogenic dominant mutation in Rom1 generated by N-ethyl-N-nitrosourea mutagenesis causes retinal degeneration in mice.

Authors:  Hajime Sato; Tomohiro Suzuki; Kyoko Ikeda; Hiroshi Masuya; Hideki Sezutsu; Hideki Kaneda; Kimio Kobayashi; Ikuo Miura; Yasuyuki Kurihara; Shunji Yokokura; Kohji Nishida; Makoto Tamai; Yoichi Gondo; Tetsuo Noda; Shigeharu Wakana
Journal:  Mol Vis       Date:  2010-03-10       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.